How Much does Lyrica Cost Without Insurance in 2024? Mira Health

The relative risk for suicidal thoughts or behavior was higher in clinical trials for epilepsy than in clinical trials for psychiatric or other conditions, but the absolute risk differences were similar for the epilepsy and psychiatric indications. This medication can cause new or worsening depression and increase the risk of suicidal thoughts and actions in a small number of people. This can happen while you are taking this medication or after stopping it. Talk to your care team right away if you have changes in mood or behavior or thoughts of self-harm or suicide. This medication may affect your coordination, reaction time, or judgment. Do not drive or operate machinery until you know how this medication affects you.

Costs

• In pediatric patients, the recommended dosing regimen is dependent upon body weight.
• This information does not take the place of talking to your healthcare provider about your medical condition or treatment.
• If you are about to harm yourself, call 911 or call or text 988, the Suicide & Crisis Lifeline.
• More than 16 million people have been prescribed Lyrica since 2005.

Patients who visited a doctor utilized healthcare resources according to results from the survey (Table 4). Drug costs included the cost of pregabalin and gabapentin (Table 5). The cost of pregabalin was based on the average trial dose of 372 mg per day. Although the cost-effectiveness of pregabalin has previously been assessed in the lyrica 75 mg price in canada UK 6 and Spain 7, no comparable studies to date have assessed the costs and health impacts for China. The objective of this study was to assess the cost-effectiveness of pregabalin compared with gabapentin in pNeP and PHN from a Chinese healthcare perspective using a China-localized adaptation of the Tarride et al. 5 model.

Drug Approvals and Databases

A significant improvement in seizure rate was observed for LYRICA 10 mg/kg/day group compared with placebo. While the 2.5 mg/kg/day group performed numerically better than placebo, this difference was not statistically significant. A secondary outcome measure included the responder rate (proportion of patients with greater than or equal to 50% reduction from baseline in partial seizure frequency). The following figure displays responder rate by dose for two of the studies. In the first study (E1), there was evidence of a dose-response relationship for total daily doses of LYRICA between 150 and 600 mg/day; a dose of 50 mg/day was not effective.

4 Adjunctive Therapy for Partial-Onset Seizures in Patients 1 Month of Age and Older

Pregabalin oral bioavailability is greater than or equal to 90% and is independent of dose. Following single- (25 to 300 mg) and multiple-dose (75 to 900 mg/day) administration, maximum plasma concentrations (Cmax) and area under the plasma concentration-time curve (AUC) values increase linearly. Following repeated administration, steady state is achieved within 24 to 48 hours.